Display options
Cite
Kovnar EH, Kellie SJ, Horowitz ME, et al. Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol. 1990;8(2):330-6doi: 10.1200/JCO.1990.8.2.330.
Kovnar, E. H., Kellie, S. J., Horowitz, M. E., Sanford, R. A., Langston, J. W., Mulhern, R. K., Jenkins, J. J., Douglass, E. C., Etcubanas, E. E., & Fairclough, D. L. (1990). Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8(2), 330-6. https://doi.org/10.1200/JCO.1990.8.2.330
Kovnar, E H, et al. "Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 8,2 (1990): 330-6. doi: https://doi.org/10.1200/JCO.1990.8.2.330
Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL. Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol. 1990 Feb;8(2):330-6. doi: 10.1200/JCO.1990.8.2.330. PMID: 2153766.
Copy Download .nbib Format: NLM
Share it on
Full text links
Atypon

J Clin Oncol. 1990 Feb;8(2):330-6. doi: 10.1200/JCO.1990.8.2.330.

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

E H Kovnar, S J Kellie, M E Horowitz, R A Sanford, J W Langston, R K Mulhern, J J Jenkins, E C Douglass, E E Etcubanas, D L Fairclough

Affiliations

  1. Department of Neurology, St Jude Children's Research Hospital, Memphis, TN 38101.

PMID: 2153766 DOI: 10.1200/JCO.1990.8.2.330

Abstract

Medulloblastoma, pineoblastoma, and cerebral neuroblastoma are malignant embryonal tumors of the CNS that may demonstrate similar histologic features, a propensity for neuraxis dissemination and sensitivity to radiation therapy and, in certain cases, chemotherapy. To evaluate the activity of preirradiation chemotherapy in such tumors, 11 newly diagnosed children with measurable residual disease and characteristics indicative of poor prognosis were treated postoperatively with cisplatin (CDDP) and etoposide (VP-16). Responses graded on the basis of radiographic findings in areas of either macroscopic residual tumor or metastatic disease included two complete responses (CRs), eight partial responses (PRs), and one stable disease (SD). Acute and subacute toxicity consisted of high-frequency hearing loss in four patients, reversible signs and symptoms of increased intracranial pressure in two patients, and transient neutropenia. Seven of eight patients with high-risk medulloblastoma and two of two with pineoblastoma remain free of tumor progression following neuraxis irradiation at 8 to 48 months postdiagnosis (median, 18 months). CDDP and VP-16 is a highly active drug combination when given before irradiation in children with high-risk medulloblastoma and other malignant embryonal tumors of the CNS, producing objective responses in at least one site of measurable disease in 10 of 11 newly diagnosed patients, including all of five with gross neuraxis dissemination.

Similar articles

Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S.
Neurooncol Pract. 2017 Sep;4(3):138-150. doi: 10.1093/nop/npx011. Epub 2017 Aug 11.
PMID: 29692919

Stosic-Opincal T, Golubicic I, Cvetkovic D, Popovic V, Antunovic V.
Neuroradiol J. 2006 Nov 30;19(5):583-8. doi: 10.1177/197140090601900504. Epub 2006 Nov 30.
PMID: 24351258

Show all 8 similar articles

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources